BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7076440)

  • 1. Contrast enhancement dynamic CT measurements and a mathematical model.
    Cassel DM; Young SW; Turner R
    Invest Radiol; 1982; 17(1):82-9. PubMed ID: 7076440
    [No Abstract]   [Full Text] [Related]  

  • 2. Computed tomography of rabbit V2 carcinoma after intraarterial contrast enhancement.
    Young SW; Enzmann D; Marglin SI
    J Comput Assist Tomogr; 1979 Apr; 3(2):185-8. PubMed ID: 429626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics.
    Young SW; Turner RJ; Castellino RA
    Radiology; 1980 Oct; 137(1 Pt 1):137-47. PubMed ID: 7422835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast enhancement of hepatic tumors in CT: comparison between bolus and infusion techniques.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1983 Feb; 140(2):291-5. PubMed ID: 6600346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic hepatic CT: uniphasic and biphasic contrast medium injection protocols.
    Drop A
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():195-204. PubMed ID: 11205764
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of hepatic VX2-carcinomas after intra-arterial, intraportal and intraparenchymal tumor cell injection. An angiographic and computed tomographic study in the rabbit.
    Burgener FA; Violante MR
    Invest Radiol; 1979; 14(5):410-4. PubMed ID: 500305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT contrast enhancement of kidney V2 carcinoma after norepinephrine and acetylcholine injection.
    Marincek B; Muller HH; Young SW
    Invest Radiol; 1981; 16(6):487-90. PubMed ID: 7319754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional imaging of the liver. New information from dynamic CT.
    Axel L; Dean PB; Moss AA; Stansberry D
    Invest Radiol; 1984; 19(1):23-9. PubMed ID: 6323343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic CT of hepatic masses with intravenous and intraarterial contrast material.
    Moss AA; Dean PB; Axel L; Goldberg HI; Glazer GM; Friedman MA
    AJR Am J Roentgenol; 1982 May; 138(5):847-52. PubMed ID: 6282093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer imaging by scanned projection radiography.
    Cassel DM; Young SW; Brody WR; Hall AL
    J Comput Assist Tomogr; 1981 Aug; 5(4):557-62. PubMed ID: 7263995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intra-arterial dynamic computed tomography in characterizing liver metastases of colorectal cancer].
    Flentje M; Hohenberger P; Adolph J; Kober B
    Rofo; 1986 Sep; 145(3):263-7. PubMed ID: 3020626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of hepatocellular carcinoma: value of dynamic CT during the arterial dominant phase with uniphasic contrast medium injection.
    Cho JS; Kwag JG; Oh YR; Han SD; Song CJ
    J Comput Assist Tomogr; 1996; 20(1):128-34. PubMed ID: 8576463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined CT during the arterial portography and CT arteriography.
    Itai Y
    Abdom Imaging; 1998; 23(3):337-8. PubMed ID: 9569310
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver enhancement techniques in computed tomography. A comparison of intravenous bolus, computed tomographic portography, and iodipamide ethyl ester particle injections in a canine model.
    Lee FT; Sproat IA; Rappe AH; Violante MR; Bronson JP
    Invest Radiol; 1994 Jun; 29 Suppl 2():S289-92. PubMed ID: 7928259
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
    Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
    Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast enhancement of focal hepatic lesions in CT: effect of size and histology.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1983 Feb; 140(2):297-301. PubMed ID: 6600347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of contrast enhancement of benign and malignant hepatic neoplasms during bolus dynamic and delayed CT.
    Freeny PC; Marks WM
    Radiology; 1986 Sep; 160(3):613-8. PubMed ID: 3016794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT evaluation of suspected hepatic metastases: comparison of techniques for i.v. contrast enhancement.
    Paushter DM; Zeman RK; Scheibler ML; Choyke PL; Jaffe MH; Clark LR
    AJR Am J Roentgenol; 1989 Feb; 152(2):267-71. PubMed ID: 2783503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast enhancement technique for dynamic hepatic computed tomographic scanning.
    Foley WD; Berland LL; Lawson TL; Smith DF; Thorsen MK
    Radiology; 1983 Jun; 147(3):797-803. PubMed ID: 6844616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative accuracy of intravenous contrast-enhanced CT versus noncontrast CT plus intravenous contrast-enhanced CT in the detection and characterization of patients with hypervascular liver metastases: a critically appraised topic.
    Sadigh G; Applegate KE; Baumgarten DA
    Acad Radiol; 2014 Jan; 21(1):113-25. PubMed ID: 24331274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.